BioPharma Resources

Drug Trial Radar · NCT07064473

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

EASi-PROTKT™ - A Phase III Double-blind, Randomised, Parallel-group Superiority Trial to Evaluate Efficacy and Safety of the Combined Use of Oral Vicadrostat (BI 690517) and Empagliflozin Compared With Placebo and Empagliflozin in Participants With Type 2 Diabetes, Hypertension and Established Cardiovascular Disease

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 11,800 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

11,800

Planned (sponsor's estimate)

Start

Jul 22, 2025

Primary completion

Dec 14, 2029

Study completion Dec 21, 2029

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
First posted
Jul 14, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empagliflozin, helps reduce cardiovascular risk in people with these conditions. The study will compare this combination to a placebo version of vicadrostat with empagliflozin. Participants are put into 2 groups randomly, which means by chance. One group takes vicadrostat and empagliflozin tablets, and the other group takes placebo tablets with empagliflozin. Placebo tablets look like vicadrostat tablets but do not contain any medicine. Participants take a tablet once per day for 2 and a half years and up to 4 years and 3 months. All participants also continue their medication for type 2 diabetes, high blood pressure, and cardiovascular disease. Participants have an equal chance of receiving the study medicine or placebo. Participants are in the study for up to 4 years and 3 months. During this time, they visit the study site regularly. During these visits, doctors collect information about participants' health and take blood samples. The doctors document when participants experience cardiovascular events. The doctors also regularly check participants' health and take note of any unwanted effects.

Conditions

  • Diabetes Mellitus, Type 2
  • Hypertension
  • Cardiovascular Diseases

Interventions

  • VicadrostatDrug

    Vicadrostat

  • EmpagliflozinDrug

    Empagliflozin

  • Placebo matching VicadrostatDrug

    Placebo matching Vicadrostat

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first event of cardiovascular (CV) death or heart failure event (HFE)Time frame: Up to 51 months

Locations

1,142 sites in 51 countries. Site status is shown where the registry gives one.

  • Pinnacle Research Group, LLC

    Anniston, Alabama · Recruiting

  • Eastern Shore Research Group

    Fairhope, Alabama · Recruiting

  • Lakeview Clinical Research

    Guntersville, Alabama · Recruiting

  • Arizona Clinical Trials - Chandler

    Chandler, Arizona · Recruiting

  • Elite Clinical Studies

    Phoenix, Arizona · Recruiting

  • Clinical Research Institute of Arizona, LLC

    Sun City West, Arizona · Recruiting

  • Fiel Family & Sports Medicine

    Tempe, Arizona · Recruiting

  • Arizona Clinical Trials

    Tucson, Arizona · Recruiting

  • Yuma Clinical Trials

    Yuma, Arizona · Recruiting

  • National Heart Institute

    Beverly Hills, California · Recruiting

  • Hope Clinical Research

    Canoga Park, California · Recruiting

  • John Muir Physician Network Clinical Research Center

    Concord, California · Recruiting

  • Velocity Clinical Research-Huntington Park

    Huntington Park, California · Recruiting

  • Velocity Clinical Research, San Diego

    La Mesa, California · Recruiting

  • First Valley Medical Group

    Lancaster, California · Recruiting

  • ARK Clinical Research

    Long Beach, California · Recruiting

  • Diabetes Associates Medical Group

    Orange, California · Recruiting

  • Empire Clinical Research

    Pomona, California · Recruiting

  • Velocity Clinical Research - San Bernardino

    San Bernardino, California · Recruiting

  • Acclaim Clinical Research

    San Diego, California · Recruiting

  • NorthBay Clinical Research, LLC

    Santa Rosa, California · Recruiting

  • The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    Torrance, California · Recruiting

  • Blue Coast Research Center, LLC

    Vista, California · Recruiting

  • Rocky Mountain Regional VA Medical Center

    Aurora, Colorado · Recruiting

  • OptumCare Clinical Trials, LLC

    Golden, Colorado · Terminated

  • Cardiology Physicians of Fairfield County - Bridgeport

    Bridgeport, Connecticut · Recruiting

  • CMR of Greater New Haven, LLC

    Hamden, Connecticut · Recruiting

  • Cardiology Associates of Fairfield County

    Stamford, Connecticut · Recruiting

  • Excel Medical Clinical Trials

    Boca Raton, Florida · Recruiting

  • Clinical Research of West Florida, Inc.

    Clearwater, Florida · Recruiting

  • Beautiful Minds Clinical Research Center

    Cutler Bay, Florida · Recruiting

  • Hillcrest Medical Research

    DeLand, Florida · Recruiting

  • University Clinical Research Deland, LLC

    DeLand, Florida · Recruiting

  • Universal Axon Clinical Research

    Doral, Florida · Recruiting

  • Northeast Research Institute

    Fleming Island, Florida · Recruiting

  • Covenant Metabolic Specialists, LLC - Fort Myers

    Fort Myers, Florida · Recruiting

  • Velocity Clinical Research-Hallandale Beach-67888

    Hallandale, Florida · Recruiting

  • Northeast Research Institute

    Jacksonville, Florida · Recruiting

  • Westside Center for Clinical Research

    Jacksonville, Florida · Recruiting

  • East Coast Institute for Research, LLC - Southside

    Jacksonville, Florida · Recruiting

Showing 40 of 1,142 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.